Biogen Will Take Alzheimer’s Therapy to FDA, Reviving Hope

The following video is brought to you courtesy of the Health News YouTube Channel. Click the video below to watch it now.

Oct.22 — Biogen Inc. will ask U.S. drug regulators to approve the company’s experimental Alzheimer’s therapy, reviving the nearly abandoned treatment after a new analysis of data from two failed clinical trials showed promising results. Bloomberg Intelligence’s Sam Fazeli has more on “Bloomberg Markets.”

Recommended Viewing


You'll LOVE these Conservative Tees & Gear!

VIEW HERE

VIEW HERE

VIEW HERE

VIEW HERE

VIEW HERE

VIEW HERE

VIEW HERE

VIEW HERE

VIEW HERE

<



Comments are closed.